youtube_live
Q2 2026 财报 • 3 天后
查看详情chevron_right
TWST:NASDAQ
Twist Bioscience Corp
US$58.45
arrow_upward
+3.09%(+1.75) 1 天
US$58.00
arrow_downward
-0.77% (-0.45)bedtime盘后交易
休市： 4月30日, GMT-4 16:00:00 · USD
search
所有股票代码
1 天
5 天
1 个月
6 个月
年初至今
1 年
5 年
最大
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 TWST 生成关键数据洞见…
开盘价
US$57.50
最高价
US$60.60
最低价
US$56.74
市值
三五.八四亿
平均成交量
一一七.五六万
成交量
一五五.二六万
52 周最高价
US$65.10
52 周最低价
US$23.30
每股收益
-US$1.27
Beta 版
二.二一
流通股数
六一三一.二〇万
员工人数
九七九
新闻报道
来自全网
资料
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Twist Bioscience Corp简介